{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-21-025575","form_type":"8-K","ticker":"BVS","cik":"0001665988","company_name":"Bioventus Inc.","filed_at":"2021-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.568643+00:00","generated_at":"2026-06-27T22:20:47.327381+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Board member David Parker resigns; Michelle McMurry-Heath elected as director at Bioventus","bullets":["David J. Parker resigned from the Board effective January 1, 2022.","Michelle McMurry-Heath elected as Class I director effective January 1, 2022.","Expected to serve on the Compliance, Ethics and Culture Committee.","Director compensation includes $55K annual cash retainer, $5K committee fee, and $152K RSU initial award."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-21-025575","json":"https://secwatch.observer/filing/0001628280-21-025575.json","markdown":"https://secwatch.observer/filing/0001628280-21-025575.md","text":"https://secwatch.observer/filing/0001628280-21-025575.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1665988/000162828021025575/0001628280-21-025575-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1665988/000162828021025575/bvs-20211220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T22:20:47.327381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"24d68ec638","claim":"Michelle McMurry-Heath was elected as Class I director at Bioventus Inc..","evidence_excerpt":"On December 21, 2021, the Board elected Michelle McMurry-Heath as a Class I director of the Board for a term ending at the 2022 annual meeting of stockholders of the Company, effective on the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1665988/000162828021025575/0001628280-21-025575-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"},{"claim_id":"7940de5679","claim":"David J. Parker resigned as Director at Bioventus Inc..","evidence_excerpt":"On December 20, 2021, David J. Parker resigned as a member of the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”), effective as of January 1, 2022 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1665988/000162828021025575/0001628280-21-025575-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}